Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
AstraZeneca
Harvard Business School
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

ZEGERID OTC Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Zegerid Otc patents expire, and what generic alternatives are available?

Zegerid Otc is a drug marketed by Bayer Healthcare Llc and is included in two NDAs.

The generic ingredient in ZEGERID OTC is omeprazole; sodium bicarbonate. There are one hundred and thirty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.

Drug patent expirations by year for ZEGERID OTC
Recent Clinical Trials for ZEGERID OTC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NorginePhase 3
BayerPhase 1
NorginePhase 1

See all ZEGERID OTC clinical trials

Recent Litigation for ZEGERID OTC

Identify potential future generic entrants

District Court Litigation
Case NameDate
ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company2015-07-01
Takeda Pharmaceutical Co v. Impax Laboratories, Inc.2013-11-19
HORIZON PHARMA, INC. v. DR. REDDY'S LABORATORIES INC.2011-04-21

See all ZEGERID OTC litigation

Synonyms for ZEGERID OTC
774595-73-2
Acitrel
LS-188023
Omeprazole / sodium bicarbonate
Omeprazole mixture with sodium bicarbonate
Omeprazole, sodium bicarbonate drug combination
omeprazole/sodium bicarbonate
Rapinex
SCHEMBL2523926
Paragraph IV (Patent) Challenges for ZEGERID OTC
Tradename Dosage Ingredient NDA Submissiondate
ZEGERID OTC CAPSULE;ORAL omeprazole; sodium bicarbonate 022281 2010-04-20

US Patents and Regulatory Information for ZEGERID OTC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZEGERID OTC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009   Start Trial   Start Trial
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013   Start Trial   Start Trial
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013   Start Trial   Start Trial
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
McKesson
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.